heart failure Flashcards

1
Q

congestive heart failureCHF p

A

inability of heart to pump blood at a rate to meet the needs of active tissues, or needs to via an elevated filling pressure

Common and recurrent condition with a poor prognosis , l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CHF pathogenesis

A

Usually results from a SLOW developing intrinsic deficit in contraction, but occasionally occurs acutely

Mechanisms: abnormal load presented to heart (acutely fluid overload MI or valve dysfunction) (chronically- ischemic heart disease, dilated cardiomyopathy, HTN)

Impaired Ventricular filling: Acutely (pericarditis, tampanode), Chronically (restrictive cardiomyopathy, severe left Ventricular hypertrophy)

Obstruction due to valve stenosis (chronic rheumatic valve disease mitral valve)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CHF characterization

A

Systolic vs diastolic dysfunction
Systolic dysfunction: progressive deterioation of cardiac contractile funciton (Ischemia, pressure volume overload, dilated cardiomyopathy)

Diastolic dysfunction (inability of heart to relax, expand and fill sufficiently during diastole) (massive left ventricular hypertrophy, amyloidosis, myocardial fibrosis, constrictive pericarditis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Compensatory mechanisms

A

Frank starling mechanism- increased preload dilation (increased end diastolic filling volume) sustains cardiac performance by enhancing contractility (lengthens fibers contract more forcibly), results in increased wall tension and increase oxygen requirements

Neurohumoral systems: release of NE by cardiac nerves increases heart rate, myocardial contractility and vascular resistance, RAAS system increases Na and water resorption, increases cardiac output and increased vasoconstriction, release of ANP (secreted from atrial myocytes when atrium is dilated, causing vasodilation, diuresis)

Cardiac hypertrophy: increases load occuring over weeks to monthes, increased number of sarcomeres, no hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

patterns of hypertrophy

A

Reflect the nature of stimulus
Pressure overload: concentric hypertrophy (HTN and aortic stenosis)

volume overload: hypertrophy accompanied by dilatation (mitral or aortic regurgitation)- eccentric hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cardiac hypertrophy and CHF

A

sustained cardiac hypertrophy often evolves to cardiac failure
Increased myocyte size results in decreased capillary density, increased intercapillary distance and increased fibrous tissue
higher cardiac oxygen consumption
Altered gene expression and roteins
Loss of myocytes due to apoptosis
LVH (hypertrophy) independent risk factor for sudden death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Left sided heart failure

A

effects primarily due to progressive damming of blood within the pulmonary circulation and diminished peripheral blood pressure and flow

Causes: ischemic heart disease, HTN, aortic and mitral valve disease, non ischemic myocardial disease (cardiomyopathies, myocarditis_

Clinical effects and morphology (LVH and often dilation, often result in mitral valve insufficiency) Secondary enlargement of left atrium –> atrial fibrillation–> stagnant blood in atrium–> thrombus embolic stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Left HF clinical effects on lung

A

increased pressure in pulmonary veins which is transmitted to capillaries and arteries
Pulmonary congestion and edema, heart failure cells, dyspnea, orthopnea (dyspnea when recumbent) and paroxysmal nocturnal dyspnea)

When supine, venous return increases and dipharagms elevate Rales on exam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Left sided HF kidneys and brain

A

Kidneys: decrease renal perfusion activats RAAS–> increased blood volume, if perfusion deficit is severe–> prerenal azotemia (impaired kidney function due to low perfusion)

Brain: cerebral hyposia and encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Right sided heart failure

A

Effects are primarily due to engorgement of systemic and potral venous systems

Causes: Secondary to left-sided failure, usually, pulmonary HTN, primary myocardial disease, tricuspid or pulmonary valvular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

R HF on heart, liver portal system, kidneys, brain, lungs

A

Heart: right ventricle responds to the increased workload with hypertrophy and often dilatation

Liver: elevated pressure in the portal vein leads to congestive hepatosplenomegaly, cardiac cirrhosis, ascites

Kidneys: congestion, fluid retention, peripheral edema, azotemia (more marked with right heart failure than left)

Brain: venous congestion and hypoxic encephalopathy

Lung: pleural and pericardial effusion, atelectasis, peripheral edema (at ankle and presarcal), eventual anasarca (generalized massive edema)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Heart failure left vs Right

A

Left: pulmonary congestion and edema prominent, kidneys have reduced perfusion, fluuid retention, azotemia less prominent, Brain: reduced perfusion, cerebral hypoxia and encephalopathy

right: Systemic and portal venous congestion (hepatosplenomagaly, peripheral edema, pleural effusion, ascites), kidneys: congesiont fluid retention and azotemia more prominent, brain: venous congestion, hypoxia and encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Heart failure

A

State in which the heart cant pump blood at a rate sufficient to meet the requirements of metabolizing tissues, or only able to do so if the cardiac filling pressures are really high

Inadequate perfusion–> retention of fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Heart failure pathophysiology

A

CVD that impairs ventricular contractility, increases afterload, impairs relaxation and filling

HF due to abnormal emptying (systolic dysfunction), filling (diastolic dysfunction)

Pts categorized according to ejection fraction : reduced EF, or preserved EF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Heart failure with reduced ejection fraction

A

Ventricle has diminished capacity to eject blood because of impaired contractility or pressure overload

Loss of contractility may result from : destruction of myocytes, abnormal myocyte function, fibrosis

With pressure overload ejection is impaired by increased resistance to outflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Heart failure wiht preserved ejection fraction

A

usually demonstrate abnormalities in diastolic function, impaired early relaxation and or increased stiffness

Acute ischemia, hypertrophy, fibrosis, restrictive cardiomyopathy, pericardial diseases

17
Q

Right sided heart failure

A

RV highly compliant
Susceptible to failure with a sudden increase in afterload
Right sided heart failure that results froma primary pulmonary Process

Cardiac causes: Left sided heart failure, pulmonic valve stenosis, right ventricular infarction

Pulmonary parenchymal disease: Chronic obstructive pulmonary disease, interstitial lung disease, chronic lung infection

Pulmonary vascular diseases: pulmonary embolism, pulmonary arteriolar hypertension

18
Q

Compensatory mechanisms of HF

A
Helps to maintain perfusion of vital organs
Neurohormanal activation (increase in RAAS, SNS and antidiuretic hormone

hypertrophy and remodeling- compensatory process that develops overtime, increases stiffness,

19
Q

Natriuretic Pepetides

A

ANP- atrial natriuretic peptide, released from atrial cells in response to stretch

BNP- B, type natriuretic peptide, produced by ventricular myocardium in response to hemodynamic stress (HF, MI)

Oppose actions of other hormone systems (promote exrection of sodium and water, produce vasodilation, inhibit renin secretion

Serum BNP level = HF, degraded by neprilysin

20
Q

Precipitating factors

A

Symptomatic for extended periods (increased metabolic demands, increased ciculating volume, increase in afterload, impaired contractility, failure to take prescribed HF meds, slow HR

21
Q

Symptoms of HF

A

Left sided: dyspnea, orthopnea, paroxysmal nocturnal dyspnea, fatigue

Right sided: peripheral edema, right upper quadrant discomfort- hepatic enlargement

Physical: diaphoresis, tachycardia, tachypnea, pulmonary rales, loud P2, S3

Jugular venous distenstion (hepatomegalu, peripheral edema

22
Q

Classification of HF

A

Class 1 mild (cardiac disease, no limitation in physical activity)
Class 2 mild (slight limitation of physical activity, dyspnea and fatigue with moderate exertion)
Class 3 moderate (limitation of physical activiity, dyspnea with minimal exertion), comfort only at rest

Class 4 severe : sever limitation of activity, symptoms present ar rest

23
Q

Prognosis

A

45-60% death rate in 5 yrs

24
Q

Treatment of HF with reduced ejection fraction

A

Diuretics, Inhibitors of RAAS (ace inhibitor, angiotensin blocker, aldosterone antagonist), B blockers, vasodilators, positive inotropic agents, HR reducing agents

Positive inotropes- Digoxin (glycoside, increase contraction and stroke volume, increases vagal tone slows HR), Secondary effects (decrease HR, arterial and venous dilation, decreased venous pressure, Blocks Na K ATpas) 36 hour half life, orally absorben, renal elimination

SE- low therapy, GIT, visual, neuro, muscular, cardiac

Doesnt prolong survival

25
Q

Diuretics

A

Promote elimination of sodium and water and therefore reduce IV volume and venous return to heart, with the decrease in preload, prevent pulmonary congestion

Loop diuretics (furosemide)- promotes K loss, hypokalemia
Thiazide diuretics (chlorothiazide)- rarely used alone, combo therapy with loop  (promotes K loss)

K sparing diuretics (amiloride, triamterene)- not the best diuretic, but spares K and Mg wasting

26
Q

Angiotensin 2 and aldosterone

A

ANG2: potent arterial constrictor, Na and water retention (stimulates aldosterone secretion), enhances sympathetic activity, arrhythmogenic,, cardiac remodeling

Aldosterone: Na and water retention and potassium secretion, promotes cardiact remodeling

27
Q

Ace inhibitors

A

Captopril and enalapril, actions in HF (decreases vascular resistance afterload by blocking arterial constricting activity of Ang 2, reduces intravascular volume and systemic conestion

Extend survival

SE: hyperkalemia, angioedema, dry cough, Hypotension, renal failure

28
Q

Angiotensin Receptor Blocker

A

Artans (losartan and valsarton), competitively block At receptors, does not prevent degradation of bradykinin

Similar to ACE inhibitors, extents survival

SE: hypotension, renal failure, hyper kalemia

ARTAN+ Neprilysin inhibitor combo (degrades vasoactive peptides ANPs, bradykinin, and others)- better than enalapril

29
Q

Aldosterone antagonists

A

Spironolactone and eplerenone

Excessive aldosterone –> fibrosis and remodeling, reduce symptoms

30
Q

Vasodilators

A

Nitrates (venous)
ACE inhibitors, Ang 2 inhibitors, Nitroprusside (Mixed)
Hydralazine (arterial)

Venous dilator- decreases preload, no stroke volume change, less wall stress

Arterial dilator- decreases afterload, increased stroke volume, decreased wall stress

Mixed: increased stroke and decreased wall stress

31
Q

Isosorbide Dinitrate/Hydralazine Combination

A

Shown to improve survival in pts with HF but less effective than ACE inhibitor

used in renal dysfunction

32
Q

Beta blocker

A

decrease arryhthmias, 2 demand, blood pressure, prevent disease progression (remodeling), inhibit cardiotoxic actions of catecholamines, reduce B receptor down regulation

Can initially worsen cardiac function, Metoprolol, carvedilol, bisoprolol

Ivabradine- blocks If

33
Q

HF w/ preserved ejetion fracture

A

Therapies used in HFrEF provide little benefit

Some benefit of aldosterone receptor blockade

Manage associated conditions

Diuretics reduce pulmonary congestion and peripheral edema

34
Q

acute heart failure

A
Volume overload (wet vs dry) consequent of levated filling pressures
Decreased cardiac output (cold vs warm consequent of reduced tissue perfusion
35
Q

Acute pulmonary edema

A

elevated capillary hydrostatic pressure– accumulation of fluid and alveolar spaces

Develops when the pulmonary capillary wedge pressure

Results in hypoxemia and severe dyspnea

Life threatening emergency

36
Q

Diuretics

A

Loop diuretics (furosemide), produce a rapid and potent diuresis, IV administration , reduce blood volume and therefor preload

37
Q

Vasodilators

A

Nitroprusside (IV, direct NO that dilates arteries and veins, reduces V filling pressure preload and systemic vasculat resistance

Helps in pt with severe HF with elevated systemic vascular resistance

Nitroglycerin: prep, induces venodilation and reduces v filling pressure

38
Q

Inotropic agents

A

Dobutamine- predominant pharm effect is B1 adrenergic receptor stimuation, increases contractility and stroke volume, little effect on peripheral vascular resistance and arterial pressure

Dopamine- dose dependant, low- D1 renal and mesentary dilation, Med- D1 and B1 renal plus increased HR and contractility, High- D1 B1 a1- vasoconstriction

39
Q

Milrinone

A

PDE inhibitor, decreases degradation of cAMP– positive inotropic effect, increased stroke volume